By special request of the US Food and Drug Administration, Briotech is invited to present its research supporting prion inactivation with use of BrioHOCl™ at the FDA Silver Springs, MD location.
United States Food and Drug Administration
February 06, 2018
High Level Inactivation of Prions and Other Infectious Pathogens with Novel Preparations of (BrioHOCl™) Hypohalous Acids
Brio Blogs
Briotech Presents Prion Research at the US FDA
Category
Most Recent
Aug 3, 2021
Jun 24, 2021
Jun 24, 2021
May 27, 2021
Empty content. Please select category to preview